Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.335 USD | +1.14% | -5.99% | +51.70% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.70% | 166M | |
+45.88% | 56.65B | |
-7.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.10% | 26.75B | |
-21.34% | 19.03B | |
+0.84% | 12.28B | |
+24.32% | 12.26B | |
+26.93% | 12.04B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Atossa Therapeutics Doses Last Patient in Phase 2 Karisma-Endoxifen Trial